0001209191-17-046040.txt : 20170724 0001209191-17-046040.hdr.sgml : 20170724 20170724061513 ACCESSION NUMBER: 0001209191-17-046040 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170720 FILED AS OF DATE: 20170724 DATE AS OF CHANGE: 20170724 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shah Sujal CENTRAL INDEX KEY: 0001588861 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36500 FILM NUMBER: 17977509 MAIL ADDRESS: STREET 1: C/O CYMABAY THERAPEUTICS, INC. STREET 2: 3876 BAY CENTER PLACE CITY: HAYWARD STATE: CA ZIP: 94545 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc. CENTRAL INDEX KEY: 0001042074 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943103561 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7999 GATEWAY BLVD STREET 2: SUITE 130 CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-293-8800 MAIL ADDRESS: STREET 1: 7999 GATEWAY BLVD STREET 2: SUITE 130 CITY: NEWARK STATE: CA ZIP: 94560 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX, INC. DATE OF NAME CHANGE: 20090721 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX INC DATE OF NAME CHANGE: 19970710 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-07-20 0 0001042074 CymaBay Therapeutics, Inc. CBAY 0001588861 Shah Sujal C/O CYMABAY THERAPEUTICS, INC. 7999 GATEWAY BOULEVARD, SUITE 130 NEWARK CA 94560 1 1 0 0 Interim President & CEO Common Stock 2017-07-20 4 P 0 891 7.29 A 75891 D Common Stock 2017-07-20 4 P 0 400 7.30 A 76291 D Common Stock 2017-07-20 4 P 0 576 7.31 A 76867 D Common Stock 2017-07-20 4 P 0 100 7.32 A 76967 D Common Stock 2017-07-20 4 P 0 8033 7.35 A 85000 D /s/ Sujal Shah 2017-07-24